Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ashley F, Berendzen"'
Autor:
Brian J. Thomas, Caitlyn Guldenpfennig, Yue Guan, Calvin Winkler, Margaret Beecher, Michaela Beedy, Ashley F. Berendzen, Lixin Ma, Mark A. Daniels, Donald H. Burke, David Porciani
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 34, Iss , Pp 102046- (2023)
A significant fraction of non-small cell lung cancer (NSCLC) cases are due to oncogenic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR). Anti-EGFR antibodies have shown limited clinical benefit for NSCLC, wherea
Externí odkaz:
https://doaj.org/article/a21d444d7c774c959bf15916e11144f4
Autor:
Terry L. Carmack, Silvia S. Jurisson, Lauren Radford, Fabio Gallazzi, Dionysia Papagiannopoulou, Michael R. Lewis, Lisa D. Watkinson, Heather M. Hennkens, Ashley F. Berendzen
Publikováno v:
Bioorganic & Medicinal Chemistry. 27:492-501
The somatostatin receptor subtype 2 (SSTR2) is often highly expressed on neuroendocrine tumors (NETs), making it a popular in vivo target for diagnostic and therapeutic approaches aimed toward management of NETs. In this work, an antagonist peptide (
Autor:
Cathy S. Cutler, Eric Dorman, Tim E. Phelps, A. Lake Wooten, Silvia S. Jurisson, Alan R. Ketring, Michael D. Phipps, D. Scott Wilbur, Donald E. Wycoff, Ashley F. Berendzen, Timothy J. Hoffman, Yutian Feng, Nkemakonam C. Okoye, Jakob E. Baumeister, Vladislav Vlasenko
Publikováno v:
Applied Radiation and Isotopes. 143:113-122
Positron-emitting 72As is the PET imaging counterpart for beta-emitting 77As. Its parent, no carrier added (n.c.a.) 72Se, was produced for a 72Se/72As generator by irradiating an enriched 7°Ge metal-graphite target via the 70Ge(α, 2 n)72Se reaction
Autor:
Lisa D. Watkinson, Fabio Gallazzi, Silvia S. Jurisson, Ashley F. Berendzen, Heather M. Hennkens, Terry L. Carmack, Lauren Radford, Michael R. Lewis, Dionysia Papagiannopoulou
Publikováno v:
Nuclear Medicine and Biology. 47:4-9
Introduction A somatostatin receptor (SSTR)-targeting antagonist peptide (sst 2 -ANT) was radiolabeled with 99m Tc tricarbonyl via a tridentate [N,S,N]-type ligand (L) to develop a radiodiagnostic agent, 99m TcL-sst 2 -ANT, for imaging of SSTR-expres
Autor:
Frederick S. vom Saal, Cynthia Besch-Williford, Julia A. Taylor, Ashley F Berendzen, Maren Bell Jones, William A. Ricke
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 11
International Journal of Molecular Sciences, Vol 21, Iss 3902, p 3902 (2020)
Volume 21
Issue 11
International Journal of Molecular Sciences, Vol 21, Iss 3902, p 3902 (2020)
Obstructive voiding disorder (OVD) occurs during aging in men and is often, but not always, associated with increased prostate size, due to benign prostatic hyperplasia (BPH), prostatitis, or prostate cancer. Estrogens are known to impact the develop
Autor:
Yutian, Feng, Michael D, Phipps, Tim E, Phelps, Nkemakonam C, Okoye, Jakob E, Baumeister, Donald E, Wycoff, Eric F, Dorman, A Lake, Wooten, Vladislav, Vlasenko, Ashley F, Berendzen, D Scott, Wilbur, Timothy J, Hoffman, Cathy S, Cutler, Alan R, Ketring, Silvia S, Jurisson
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 143
Positron-emitting
Publikováno v:
Cancer Research. 75:4412-4412
Purpose: Peptide receptor targeted therapy for treatment of castration resistant prostate cancer (CRPC) has been explored by several groups including our own. However limitations in tumor drug delivery and transient retention at the tumor site has re
Autor:
Tammy L. Rold, Timothy J. Hoffman, Lixin Ma, Jillian C. Rushin, Ashley F. Berendzen, Nicole E. Bernskoetter
Publikováno v:
Cancer Research. 74:4927-4927
Introduction: Recent progress in developing BB2r (bombesin receptor subtype 2) antagonist vectors with long term cellular retention has captured significant interest for in vivo targeting of BB2r positive tumor cells using diagnostic and therapeutic